Long-read RNA sequencing of archival tissues reveals novel genes and transcripts associated with clear cell renal cell carcinoma recurrence and immune evasion.


Journal

Genome research
ISSN: 1549-5469
Titre abrégé: Genome Res
Pays: United States
ID NLM: 9518021

Informations de publication

Date de publication:
16 Sep 2024
Historique:
received: 19 12 2023
accepted: 10 09 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: aheadofprint

Résumé

The use of long-read direct RNA sequencing (DRS) and PCR cDNA sequencing (PCS) in clinical oncology remains limited, with no direct comparison between the two methods. We used DRS and PCS to study clear cell renal cell carcinoma (ccRCC), focussing on new transcript and gene discovery. Twelve primary ccRCC archival tumors, six from patients who went on to relapse, were analysed. Results were validated in an independent cohort of twenty patients by qRT-PCR and compared to DRS analysis of RCC4 cells. In archival clinical samples and due to long-term storage, average read length was lower (400-500nt) than that achieved through DRS of RCC4 cells (>1100nt). Still, deconvolution analysis showed a loss of immune infiltrate in primary tumors of patients who relapse as reported by others. Differentially expressed genes in patients who went on to relapse were determined with good overlap between DRS and PCS, identifying

Identifiants

pubmed: 39284687
pii: gr.278801.123
doi: 10.1101/gr.278801.123
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Published by Cold Spring Harbor Laboratory Press.

Auteurs

Joshua Lee (J)

Hull York Medical School, York Biomedical Research Institute, University of York.

Elizabeth A Snell (EA)

Oxford Nanopore Technologies.

Joanne Brown (J)

Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital.

Charlotte Elizabeth Booth (CE)

Hull York Medical School, York Biomedical Research Institute, University of York.

Rosamonde E Banks (RE)

Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital.

Daniel J Turner (DJ)

Oxford Nanopore Technologies.

Naveen Vasudev (N)

Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital.

Dimitris Lagos (D)

Hull York Medical School, York Biomedical Research Institute, University of York; dimitris.lagos@york.ac.uk.

Classifications MeSH